Neuphoria Therapeutics Inc. (NEUP)
Market Closed
11 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
3. 81
-0.03
-0.7812%
After Hours
$
+0.15 +3.937% 3. 96
20.65M Market Cap
- P/E Ratio
- Div Yield
30,095 Volume
- Eps
$ 3.84
Previous Close Investors:
Want to track NEUP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neuphoria Therapeutics Inc. (NEUP) Statistics
Valuation metrics
Market Cap 20.65M
Enterprise value 1.24M
Trailing P/E (ttm) -0.35
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) -1.97
Price/Book (mrq) 0.7
Enterprise Value/Revenue -0.12
Enterprise Value/EBITDA -0.05
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 53.85K
Average volume (90 days) 433.77K
Price summary
52-Week low 3.19
52-Week high 21.4
Beta -
50-Day moving average 3.82
200-Day moving average 4.49
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:12
Last split Date 24 Dec 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 2.72%
Operating margin 2.31%
Operational effectiveness
Return on assets -0.82%
Return on equity -1.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -1.94
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -5.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.59
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 14.31%
Book value per share (mrq) 5.44
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
